ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
0,00%
Bitcoin
104.627,19
-0,10%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Deutschland
  5. TG

  6. Westport Fuel Systems Inc (WPI) Börsenkurse

Westport Fuel Systems Inc

Westport Fuel Systems Inc (WPI)

TG
4,23
0,01
(0,24%)
Geschlossen 26 Januar 10:00PM
Echtzeitdaten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
4,23
Gebot
4,165
Fragen
4,29
Volumen
400
4,175 Tagesbereich 4,175
0,00 52-Wochen-Bereich 0,00
Handelsende
4,22
Handelsbeginn
4,175
Letzte Trade
400
@
4.175
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

WPI Neueste Nachrichten

Weitere Nachrichten

Watson Files FDA Application for Generic Nuvigil(R)

- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Jan. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global specialty pharmaceutical company, today confirmed...

06 Januar 2010
PR Newswire (US)

Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Depriva

MORRISTOWN, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today announced a new program encouraging health professionals to help maintain the bone health of...

14 Dezember 2009
PR Newswire (US)

Watson Files FDA Application for Generic Rozerem(R)

- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global specialty pharmaceutical company, today confirmed...

04 Dezember 2009
PR Newswire (US)

Watson to Present at Credit Suisse Healthcare Conference

MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and...

06 November 2009
PR Newswire (US)

Watson and Barr Settle Lawsuit Over Oxytrol(R)

CORONA, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories...

28 Oktober 2009
PR Newswire (US)

Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands

MORRISTOWN, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals (NYSE:WPI), a leader in generic and specialty branded pharmaceuticals, announced today that G. Frederick Wilkinson has...

21 September 2009
PR Newswire (US)

Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use

MORRISTOWN, N.J., Aug. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories...

28 August 2009
PR Newswire (US)

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

MORRISTOWN, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories...

03 August 2009
PR Newswire (US)

Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)

MORRISTOWN, N.J., July 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded pharmaceuticals, today announced a license agreement with...

28 Juli 2009
PR Newswire (US)

Watson CFO Mark W. Durand to Take Leave of Absence

MORRISTOWN, N.J., July 27 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded pharmaceuticals, announced that effective today Mark W...

27 Juli 2009
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

WPI - Frequently Asked Questions (FAQ)

What is the current Westport Fuel Systems share price?
The current share price of Westport Fuel Systems is 4,23 €
What is the 1 year trading range for Westport Fuel Systems share price?
Westport Fuel Systems has traded in the range of 0,00 € to 0,00 € during the past year

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
LL3PanGenomic Health Inc
0,2999 €
(67,26%)
2,89k
VAR1Varta AG
1,00 €
(37,93%)
3,62M
FP9Five Point Holdings LLC
5,35 €
(36,48%)
20
UD9Mason Resources Inc
0,0616 €
(36,28%)
28k
8CTCannabix Technologies Inc
0,32 €
(33,33%)
250
E3TMetavista 3D Inc
1,49 €
(-50,99%)
5,26M
E3O1Nexoptic Technology Corp
0,008 €
(-48,39%)
34,02k
POTAPortofino Resources Inc
0,0032 €
(-38,46%)
150k
G12Global Atomic Corp
0,425 €
(-31,95%)
729,18k
1UR1Bee Vectoring Technologies International Inc
0,0035 €
(-30,00%)
139,6k
PF8European Lithium Limited
0,0348 €
(-3,33%)
9,79M
E3TMetavista 3D Inc
1,49 €
(-50,99%)
5,26M
D7GNel ASA
0,1932 €
(0,99%)
4,13M
0QJHexagon Purus ASA
0,2725 €
(-22,59%)
3,99M
VAR1Varta AG
1,00 €
(37,93%)
3,62M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TG
WPI
Westport Fuel Systems
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten